Keybanc Upgrades GoodRx Holdings to Overweight, Announces $9 Price Target
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Scott Schoenhaus upgrades GoodRx Holdings (GDRX) from Sector Weight to Overweight and sets a $9 price target.

April 10, 2024 | 8:40 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GoodRx Holdings upgraded by Keybanc from Sector Weight to Overweight with a new price target of $9.
Upgrades by analysts, especially to an Overweight rating, indicate a positive outlook on the stock, suggesting potential outperformance in the market. The new price target of $9 further emphasizes the analyst's bullish stance on GoodRx Holdings, likely leading to increased investor interest and potentially driving the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100